Literature DB >> 27509984

Expression of Epstein Barr Virus Encoded EBNA1 and LMP1 Oncoproteins in Nasopharyngeal Carcinomas from Northeast India.

Parikhit Borthakur1, Kangkana Kataki, Chenole Keppen, V Khamo, Subhash Medhi, Manab Deka.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC), a malignancy arising from the epithelial lining of the nasopharynx, is distinct from others cancers in terms of its epidemiologic features. It is rare in most parts of the world except for a few regions with populations of Mongoloid origin.
OBJECTIVES: To study the expression pattern of Epstein Barr virus (EBV) encoded oncoproteins EBNA1 and LMP1 in different histological types of NPC and to correlate expression patterns with sex, age and histological types.
MATERIALS AND METHODS: A total of 40 formalinfixed, paraffinembedded NPC biopsy samples and tissues from 20 healthy controls were collected to study the expression level of EBNA1 and LMP1 using immunohistochemistry.
RESULTS: EBNA1 and LMP1 expression was found in 92.5% and 90% respectively, of the cases and none of the control specimens. The expression patterns of EBNA1 and LMP1 were determined to be statistically significant (p<0.05) when correlated with sex, age and histological distributions. Also immunohistochemistry was found to be a sensitive technique in the detection of EBV.
CONCLUSIONS: The study reveals that the potent oncoproteins EBNA1 and LMP1 were over expressed in our population cohort. Our findings are to some extent inconsistent with earlier reports as our population showed a higher expression of both EBNA1 and LMP1 compared to other studies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27509984

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

Review 1.  Potential Role of Epstein-Barr Virus in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Scoping Review.

Authors:  Rifat Rahman; Divya Gopinath; Waranun Buajeeb; Sopee Poomsawat; Newell W Johnson
Journal:  Viruses       Date:  2022-04-13       Impact factor: 5.818

2.  Frequency of Epstein Barr Virus Type 1 Among Nasopharyngeal Carcinomas in Iranian Patients

Authors:  Toran Shahani; Manoochehr Makvandi; Alireza Samarbafzadeh; Ali Teimoori; Nastran Ranjbar; Nader saki; Soheila Nikakhlagh; Niloofar Neisi; Zeinab Hosseini; Samira Pourrezaei; Abdolnabi Shabani; Hashem Radmehr; Hamide Mehravaran; Hadis Kiani; Azadeh Haghi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

3.  Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.

Authors:  Richmond Ayee; Maame Ekua Oforiwaa Ofori; Emmanuel Ayitey Tagoe; Sylvester Languon; Kafui Searyoh; Louis Armooh; Estella Bilson-Amoah; Kenneth Baidoo; Emmanuel Kitcher; Edward Wright; Osbourne Quaye
Journal:  Viruses       Date:  2020-07-16       Impact factor: 5.048

4.  Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.

Authors:  Heng Zhou; Yu Liu; Chao Wang; Limei Liu; Huan Wang; Yaqian Zhang; Cong Long; Xiaoping Sun
Journal:  J Exp Clin Cancer Res       Date:  2018-08-15

Review 5.  Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update.

Authors:  Maria K Smatti; Duaa W Al-Sadeq; Nadima H Ali; Gianfranco Pintus; Haissam Abou-Saleh; Gheyath K Nasrallah
Journal:  Front Oncol       Date:  2018-06-13       Impact factor: 6.244

6.  Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma.

Authors:  Valerie E Salano; Amos R Mwakigonja; Ashfaq Abdulshakoor; Aveline A Kahinga; Enica M Richard
Journal:  JCO Glob Oncol       Date:  2021-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.